These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 17436714

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S, Fiore M.
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.
    Asche C, McAdam-Marx C, Seal B, Crookston B, Mullins CD.
    J Antimicrob Chemother; 2008 May; 61(5):1162-8. PubMed ID: 18310136
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S.
    J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
    [No Abstract] [Full Text] [Related]

  • 27. Community-acquired pneumonia: treatment at home or in the hospital?
    Aujesky D, Fine MJ.
    Am J Med; 2008 Dec; 121(12):1038-40. PubMed ID: 19028194
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fluoroquinolones should not be the first-line antibiotics to treat community-acquired pneumonia in areas of tuberculosis endemicity.
    Singh A.
    Clin Infect Dis; 2007 Jul 01; 45(1):133; author reply 134-5. PubMed ID: 17554716
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Impact of guidelines on outcome: the evidence.
    Martínez R, Reyes S, Lorenzo MJ, Menéndez R.
    Semin Respir Crit Care Med; 2009 Apr 01; 30(2):172-8. PubMed ID: 19296417
    [Abstract] [Full Text] [Related]

  • 38. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN, Kaatz GW, Rucker LR, Rybak MJ.
    J Antimicrob Chemother; 2008 Dec 01; 62(6):1305-10. PubMed ID: 18801920
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [High mortality. Elderly pneumonia patients need aggressive therapy].
    Stiefelhagen P.
    MMW Fortschr Med; 2008 Oct 23; 150(43):15. PubMed ID: 19031578
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.